Showing 20 of 32 recruiting trials for “beta-thalassemia-major”
RecruitingNCT07215975 ↗
A Real-World Study to Evaluate Luspatercept in Adults With Transfusion-Dependent Beta-Thalassemia in the Middle East
Enrolling by InvitationNCT07055503 ↗
Use of the Hemanext One® Hypoxic Red Blood Cell Storage System for Transfusion in Thalassemia Patients
👨⚕️ Antonis Kattamis, Professor, National and Kapodistrian University of Athens📍 1 site📅 Started Nov 2025View details ↗
Evaluation of Physiological and Psychological Factors Involved in Exercise Intolerance in Patients With β-TTD
Enrolling by InvitationNCT06717932 ↗
A Follow-up Study to Evaluate the Long-term Safety and Efficacy in Participants Who Received CS-101 Injection
ALS20-101 Lentiviral Gene Therapy for Beta Thalassemia
👨⚕️ Janet Kwiatkowski, MD, Children's Hospital of Philadelphia📍 1 site📅 Started Apr 2025View details ↗
Enrolling by InvitationNCT06685536 ↗
A Long-term Follow-up Study in Participants Who Received CS-101
👨⚕️ Yongrong Lai, M.D., First Affiliated Hospital of Guangxi Medical University📍 1 site📅 Started Jan 2025View details ↗
A Multiple Ascending Dose Study of 9MW3011 in Patients With Non-transfusion-dependent β-thalassemia
Clinical Study of Super Transplantation in the Treatment of Severe β-thalassemia
👨⚕️ Hua Jiang, PHD, Guangzhou Medical University Affiliated Women's and Children's Medical Center📍 2 sites📅 Started Oct 2024View details ↗
A Study to Test the Safety, Tolerability, and Efficacy of an Antibody, REGN7999, Injected Under the Skin for the Treatment of Iron Overload in Adult Participants With Non-Transfusion Dependent β-thalassemia, Using MRI Scans to Measure Iron Levels in the Body
Effects of Hydroxyurea and Metformin in Transfusion Dependent Beta-Thalassemia
Adherence of Beta Thalssemia Patients to Oral Chelation Therapy
A Long-term Follow-up Study in Participants Who Received CS-101
👨⚕️ Xiaowen Zhai, M.D., Children's Hospital of Fudan University📍 1 site📅 Started Jun 2024View details ↗
Inspiratory Muscle Training in Children With Beta Thalasemia
👨⚕️ hagar el-hadidy, lecturer, Faculty of Physical Therapy, Ahram Canadian University (ACU), Giza, Egypt📍 1 site📅 Started Jun 2024View details ↗
An Open-label Study of a Gene Therapy Product (Vebeglogene Autotemcel) in Transfusion Dependent Beta-Thalassemia
Unraveling the Impact of Thalidomide at Diverse Doses in Transfusion Dependent Beta Thalassemia
🏥 National Institute of Blood and Marrow Transplant (NIBMT), Pakistan📍 1 site📅 Started Apr 2024View details ↗
Β-Thalassemia Treatment with KL003 Cell Injection
RecruitingNCT06073860 ↗
A Post-Marketing Surveillance Study to Assess Safety of Luspatercept in Korean Patients With Myelodysplastic Syndrome or β-thalassemia
CS-101 in Patients With β-thalassemia
👨⚕️ Yongrong Lai, M.D., First Affiliated Hospital of Guangxi Medical University📍 1 site📅 Started Mar 2024View details ↗
RecruitingNCT06271512 ↗
A Study of Participants with Β-Thalassemia Treated with Betibeglogene Autotemcel
A Phase 1 Study of Gene-modified Autologous Hematopoietic Stem Cell (BD211) Treating β-thalassemia Major
👨⚕️ Sujiang Zhang, M.D., Shanghai Ruijin Hospital, Shanghai Jiaotong University📍 3 sites📅 Started Jan 2024View details ↗
Page 1 of 2Next →
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →